Clinical Trials Browser

INDUSTRY × Arthritis, Rheumatoid × Clear all

NCT07137598 2026-03-06

A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)

Phase 2 Recruiting

Arthritis, Rheumatoid

NCT06712628 2026-02-17

UP-RISING

Arthritis, Rheumatoid

NCT03270982 2025-12-23

Comprehensive Segmental Revision System

Active not recruiting

Arthritis, Rheumatoid, Neoplasms, Wounds and Injuries

NCT05413044 2025-12-08

A Post-marketing Study to Assess the Safety of Abatacept in Sweden Using the Swedish Rheumatology Quality Register (SRQ) Register

140,706 enrolled

Arthritis, Rheumatoid, Neoplasms, Arthritis, Psoriatic

NCT05421442 2025-12-08

DANBIO

38,396 enrolled

Arthritis, Rheumatoid, Neoplasms, Arthritis, Psoriatic

NCT05796245 2025-06-04

A Study to Learn About the Study Medicine Called Infliximab (Genetical Recombination)[Infliximab Biosimilar 3] in People With Rheumatoid Arthritis, Ulcerative Colitis, Crohn's Disease, or Psoriasis

2,207 enrolled 10 charts

Arthritis, Rheumatoid, Colitis, Ulcerative, Crohn Disease, Psoriasis

NCT05615246 2025-01-27

HRP

Arthritis, Rheumatoid, Neoplasms

NCT06583395 2024-11-01

QUANTUM

Enrolling by invitation

BreastCNSDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckLymphoidThoracic

Amyotrophic Lateral Sclerosis, Anxiety Disorders, Arthritis, Rheumatoid, Asthma, Atrial Fibrillation, Brain Neoplasms, Breast Neoplasms, Cerebral Palsy, Cluster Headache, Colitis, Ulcerative, Colonic Neoplasms, Crohn Disease, Deafness, Depression, Diabetes Mellitus, Eczema, Epilepsy, Fibromyalgia, Heart Failure, Hypertension, Hyperthyroidism, Hypothyroidism, Infertility, Leiomyoma, Lung Neoplasms, Lyme Disease, Lymphoma, Macular Degeneration, Migraine Disorders, Multiple Sclerosis, Neoplasms, Osteoarthritis, Osteoporosis, Ovarian Cysts, Ovarian Neoplasms, Parkinson Disease, Phantom Limb, Prostatic Neoplasms, Psoriasis, Skin Neoplasms, Spinal Cord Injuries, Spinal Stenosis, Stress Disorders, Post-Traumatic, Thyroid Neoplasms, Tinnitus, Fatigue Syndrome, Chronic, Tension-Type Headache, Stroke, Pulmonary Disease, Chronic Obstructive, Irritable Bowel Syndrome, Renal Insufficiency, Chronic, Angina, Stable

NCT03016013 2024-09-26

A Study of the Efficacy and Safety of TACI-antibody Fusion Protein Injection (RC18) in Subjects with Inadequate Response to MTX Due to Treat Moderate and Severe Rheumatoid Arthritis.

Phase 3 Completed

Arthritis, Rheumatoid, Lymphoma, Follicular

NCT06175338 2024-09-19

Study, Evaluating Pharmacokinetics, Pharmacodynamics, Immunogenicity and Safety Profiles of Rituximab Compared to MabThera® in Patients With Rheumatoid Arthritis

Phase 1 Active not recruiting

Arthritis, Rheumatoid

NCT01242488 2024-07-17

Efficacy and Safety of CDP6038 in Patients With Rheumatoid Arthritis With an Unsuccessful Response to Anti-Tumor Necrosis Factor (Anti-TNF) Therapy

Phase 2 Completed

Arthritis, Rheumatoid

NCT04721821 2024-04-12

Comparative Effectiveness Of Tumor Necrosis Factor Inhibitors And Tofacitinib Use In Earlier Lines Of Therapy And Use As Monotherapy.

7,807 enrolled 73 charts

Arthritis, Rheumatoid

NCT02760433 2023-09-21

CREDO 3

Phase 3 Completed

368 enrolled 21 charts

Arthritis, Rheumatoid

NCT02822495 2023-06-15

Expanded Access Protocol for Tabelecleucel for Patients With Epstein-Barr Virus-Associated Viremia or Malignancies

No longer available

Head & NeckLymphoidSarcoma

Nasopharyngeal Carcinoma, Primary Immunodeficiency Diseases, Arthritis, Rheumatoid, Infections, Leiomyosarcoma, Lymphoma, Lymphoproliferative Disorders, Inflammatory Bowel Diseases, Lymphoma, AIDS-Related, Epstein-Barr Virus Infections

NCT00048321 2022-12-05

ISIS 104838, an Inhibitor of Tumor Necrosis Factor, for Active Rheumatoid Arthritis

Phase 2 Completed

Arthritis, Rheumatoid

NCT03670667 2022-05-18

A Study to Determine the Risk of Cancer in Rheumatoid Arthritis (RA) Patients Who Use Abatacept and Other Biologic Agents

Arthritis, Rheumatoid

NCT03449758 2022-04-28

SariPRO

Phase 4 Completed

84 enrolled 36 charts

Arthritis, Rheumatoid

NCT03663829 2022-03-09

Impact of Anti-citrullinated Protein Antibody Status on Treatment Response and Treatment Persistence in Participants With Rheumatoid Arthritis (RA) Who Are Treated With Abatacept or Tumor Necrosis Factor Inhibitors in Australia

Arthritis, Rheumatoid

NCT01960855 2021-08-24

A Study Investigating the Efficacy and Safety of ABT-494 Given With Methotrexate in Subjects With Rheumatoid Arthritis Who Failed Anti-Tumor Necrosis Factor (TNF) Biologic Therapy

Phase 2 Completed

276 enrolled 14 charts

Arthritis, Arthritis, Rheumatoid, Joint Diseases, Musculoskeletal Diseases

NCT02092467 2021-08-17

Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis

Phase 4 Completed

4,372 enrolled 22 charts

Arthritis, Rheumatoid

NCT01764321 2020-12-22

NexT

Arthritis, Rheumatoid

NCT03348046 2020-03-04

PASSRRA

Arthritis, Rheumatoid, Autoimmune Diseases

NCT03001219 2020-01-29

A Study of RO7123520 to Evaluate the Safety and Efficacy in Participants With Moderately To Severely Active Rheumatoid Arthritis (RA) Who Are Inadequately Responding to Anti-Tumor Necrosis Factor (TNF)-Alpha Therapy

Phase 2 Terminated

109 enrolled 24 charts

Arthritis, Rheumatoid

NCT01721044 2019-09-18

RA-BEACON

Phase 3 Completed

527 enrolled 37 charts

Arthritis, Rheumatoid

NCT02882087 2019-04-03

A Study of the Efficacy and Safety of TACI-antibody Fusion Protein Injection (RC18) in Subjects With Inadequate Response to TNF-α Antagonists Due to Treat Moderate and Severe Rheumatoid Arthritis

Phase 2 Terminated

Arthritis, Rheumatoid, Lymphoma, Follicular

NCT00960440 2018-12-19

Study of CP-690,550 Versus Placebo In Rheumatoid Arthritis Patients On Background Methotrexate With Inadequate Response To Tumor Necrosis Factor (TNF) Inhibitors

Phase 3 Completed

399 enrolled 51 charts

Arthritis, Rheumatoid

NCT02046603 2018-12-07

ACT-MOVE

Phase 3 Completed

162 enrolled 30 charts

Arthritis, Rheumatoid

NCT02679001 2018-07-26

A Comparative Study to Observe the Effect of Concomitant Use of Corticosteroid Treatment in Rheumatoid Arthritis (RA) Participants Who Are Treated With a Tumor Necrosis Factor (TNF) Inhibitor or Tocilizumab (TCZ) as Their Second Biological Treatment.

Arthritis, Rheumatoid

NCT02862574 2018-06-27

Andecaliximab as Add-On Therapy to a Tumor Necrosis Factor Inhibitor and Methotrexate Regimen in Adults With Moderately to Severely Active Rheumatoid Arthritis

Phase 2 Terminated

15 enrolled 11 charts

Arthritis, Rheumatoid

NCT00503425 2017-08-15

A Study of MabThera (Rituximab) in Participants With Rheumatoid Arthritis Who Have Had an Inadequate Response to Disease-Modifying Antirheumatic Drugs (DMARD) and/or Anti-Tumor Necrosis Factor (Anti-TNF) Therapy.

Phase 3 Completed

215 enrolled 9 charts

Arthritis, Rheumatoid

NCT01362062 2017-08-02

Study to Evaluate the Safety, Tolerability and Efficacy of Tocilizumab in Participants With Rheumatoid Arthritis (RA) Who Have an Inadequate Response to Non-Biologic Disease Modifying Anti-rheumatic Drugs (DMARDs) and/or Anti-tumor Necrosis Factor (Anti-TNF) Therapy

110 enrolled 19 charts

Arthritis, Rheumatoid

NCT00357903 2017-02-09

Open-Label Extension Treatment With Etanercept (TNFR:Fc) for Participating Patients in Etanercept (TNFR:Fc) Clinical Trials

Phase 3 Completed

639 enrolled 27 charts

Arthritis, Rheumatoid

NCT01715896 2016-10-31

A Study of Mavrilimumab Versus Anti Tumor Necrosis Factor in Subjects With Rheumatoid Arthritis

Phase 2 Completed

215 enrolled 37 charts

Arthritis, Rheumatoid

NCT01613027 2016-10-24

An Observational Study of MabThera in Participants With Severe Active Rheumatoid Arthritis

135 enrolled 21 charts

Arthritis, Rheumatoid

NCT01641952 2016-08-17

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Rheumatoid Arthritis and an Inadequate Response or Intolerance to One Anti-Tumor Necrosis Factor (Anti-TNF) Agent

505 enrolled 15 charts

Arthritis, Rheumatoid

NCT01309282 2016-08-12

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Sero-Positive Rheumatoid Arthritis Who Are Non-Responders or Intolerant to a Single TNF-Inhibitor (PORTSMAB)

9 enrolled 17 charts

Arthritis, Rheumatoid

NCT02519387 2016-07-20

Efficacy and Safety of Buprenorphine Transdermal Patch in Non-cancer Pain of Moderate Intensity

Phase 4 Completed

78 enrolled 9 charts

Arthritis, Rheumatoid, Osteoarthritis, Low Back Pain, Arthralgia, Myalgia

NCT01350804 2016-05-23

NURTURE 1

Phase 3 Completed

551 enrolled 19 charts

Arthritis, Rheumatoid

NCT01390545 2016-04-13

VELVET

Phase 2 Terminated

Arthritis, Rheumatoid

NCT01069419 2015-10-29

FasT

1,117 enrolled 10 charts

Arthritis, Rheumatoid

NCT00883753 2014-08-06

An Extension to Study MA21573, Evaluating Tocilizumab in Patients With Active Rheumatoid Arthritis and an Inadequate Response to Current Non-Biological DMARDs and/or Anti-tumor Necrosis Factor (TNF) Therapy

Phase 3 Completed

934 enrolled 40 charts

Arthritis, Rheumatoid

NCT00361335 2014-07-29

A Study of Safety and Effectiveness of Golimumab in Participants With Active Rheumatoid Arthritis Despite Methotrexate Therapy

Phase 3 Completed

643 enrolled 14 charts

Arthritis, Rheumatoid

NCT01283971 2014-02-10

A Study of RoActemra/Actemra (Tocilizumab) Versus Adalimumab in Combination With Methotrexate (MTX) in Patients With Moderate to Severe Active Rheumatoid Arthritis And an Inadequate Response to Treatment With Only One Tumor Necrosis Factor (TNF)-Inhibitor

Phase 4 Terminated

96 enrolled 27 charts

Arthritis, Rheumatoid

NCT01463059 2013-03-25

Efficacy and Safety of Olokizumab With Rheumatoid Arthritis With Previously Failed to Anti-tumor Necrosis Factor (Anti-TNF) Therapy

Phase 2 Completed

Arthritis, Rheumatoid

NCT01294722 2013-03-19

A Study to Determine the Number of Participants With Rheumatoid Arthritis (RA) Who Meet the Requirements for Treatment With Anti-Tumor Necrosis Factor α (TNFα) in a General Hospital Setting in Korea

Arthritis, Rheumatoid

NCT00048581 2011-11-21

Phase III Study of BMS-188667 (CTLA4Ig) in Patients With Rheumatoid Arthritis Who Are Currently Failing Anti-TNF Therapy or Who Have Failed Anti-TNF Therapy in the Past.

Phase 3 Completed

738 enrolled 84 charts

Arthritis, Rheumatoid

NCT01078571 2011-10-28

DALI

705 enrolled 15 charts

Arthritis, Rheumatoid

NCT00537667 2009-11-26

The SPECTRA Study

Phase 2 Terminated

Arthritis, Rheumatoid, Inflammation

NCT00035334 2006-02-14

Study of the Safety and Efficacy of NC-503 in Secondary (AA) Amyloidosis

Phase 2/3 Completed

GastrointestinalGenitourinaryPlasma cell

Amyloidosis, Arthritis, Rheumatoid, Gastrointestinal Diseases, Kidney Diseases, Neoplasm Metastasis, Nephrotic Syndrome, Familial Mediterranean Fever